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Abstract
Purpose Correlate OCT-derived measures of
drusen and retinal pigment epithelium (RPE)
atrophy areas (RAs) with demographic
features in an elderly population.
Patients and methods Subjects aged 50 years
and older underwent Cirrus OCT scanning.
Drusen area and volume were obtained from
the macula within a central circle (CC) of
3 mm and a surrounding perifoveal ring (PR)
of 3–5 mm, using the RPE analysis software
(6.0). RA measurements were generated for
the 6 6 mm2 retinal area. Gender, age,
smoking status, and systolic blood pressure
(SBP) were considered.
Results A total of 434 eyes were included.
RA was larger in women (0.63±0.16 vs
0.26±0.08 mm2, P¼ 0.05) and with increasing
age. The PR drusen area increased with
increasing age (Po0.001), whereas the CC
drusen area remained stable after the age of
70 years (0.25±0.06 mm2 for ages 70–79 years
and 0.25±0.07 mm2 for ages 480 years). Drusen
volume in the CC was smaller after the age of
80 years (0.009±0.003 mm3) compared with the
70- to 79-year-old group (0.02±0.008 mm3).
Drusen measurements were similar between
smokers and nonsmokers, but the PR drusen
area (0.29 mm2, P¼ 0.05) and volume (0.40 mm3,
P¼ 0.005) were correlated with years smoked.
RA (0.24 mm2, P¼ 0.10), PR drusen area
(0.29 mm2, P¼ 0.05), and volume (0.40 mm3,
P¼ 0.005) were found to be directly associated
with SBP. There was a high correlation
between the eyes of the same subject.
Conclusion OCT-based automated algorithms
can be used to analyze and describe drusen
and geographic atrophy burden in such
population-based studies of elderly patients.
Eye (2015) 29, 272–279; doi:10.1038/eye.2014.260;
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Introduction
Age-related macular degeneration (AMD) is the
leading cause of irreversible, severe visual loss
in developed countries among people of age 50
years and older.1 Several studies have identified
a multitude of potential risk factors associated
with AMD, but the results have not always been
conclusive.2 Aside from age and cigarette
smoking, previous findings of associations
between AMD and other risk factors, such as
hypertension, alcohol consumption, systolic
blood pressure (SBP), sunlight exposure, and
cardiovascular disease, have been inconsistent.3
Drusen—in particular the large drusen
associated with pigment epithelium
abnormalities—are a known risk factor for
progression to advanced AMD. Drusens are
extracellular deposits that accumulate between
the retinal pigment epithelium (RPE) and the
inner collagenous layer of Bruch’s membrane.4
Geographic atrophy (GA) occurs in the late
stage of non-neovascular AMD and is the
second most common cause of severe visual loss
due to AMD, the most common being choroidal
neovascularization.5 GA is characterized by the
development and gradual enlargement of
atrophic patches that involve the RPE, the
overlying neurosensory retina, and the
underlying choriocapillaris.6
Bilateral involvement of drusen and late-stage
AMD have long been recognized,7–9 and
concordance or symmetry between eyes has
been demonstrated for the individual
phenotypes. Those studies were based on
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clinical examination or postmortem hitopathological
analysis.10 Until recently, color fundus photography was
the only imaging modality used to evaluate the severity
and progression of AMD in major epidemiologic eye
disease studies.11 However, this imaging technique has
limitations with regard to the measurement of the
geometric area of RPE atrophy and to the precise
quantification of drusen boundaries. Measurement of
these types of data is confounded on color fundus
photography by interpatient variability of fundus
pigmentation and media opacities12 and by the exposure
settings used.
Optical coherence tomography (OCT) provides the
opportunity to assess the effect of drusen and RPE
atrophy area (RA) on the geometry of the RPE in vivo.13
Segmentation algorithms have been developed to extract
quantitative information from the new spectral-domain
(SD)-OCT data. Quantification of drusen and RA has
been demonstrated with both manual and automated
strategies,14 and recently automated quantification
techniques have become available in commercial
SD-OCT (Carl Zeiss Meditec Inc, Dublin, CA,
USA) software. Validation of the accuracy and
reproducibility13,15,16 of these fully automated algorithms
has created an opportunity to study AMD lesions in
population studies.17 To our knowledge, the
epidemiologic features of AMD have not previously been
associated with automated OCT quantification data.
Herein, we describe OCT-derived measures of drusen
and RA in an elderly population and correlate these OCT
findings with other demographic features.
Methods
Subjects
An ongoing study to identify multiple eye diseases in the
Old Order Amish community living in Lancaster and
Franklin counties in Pennsylvania has identified a large
number of Amish individuals with early–late-onset
AMD. Details of the epidemiology of AMD in this
population are being isolated in an attempt to elucidate
genetic factors that may confer susceptibility and
predispose some Amish individuals and their families to
developing AMD. The current study, approved by the
Institutional Review Board of the University of
Pennsylvania, was instituted as an investigation to assess
the value of the OCT images and quantify changes
related to AMD in the macula.
Study participants, all aged 50 years and older, were
asked to complete a brief questionnaire about personal
exposures. Present or past cigarette smoking history
and number of years smoked were self-reported.
A qualified examiner obtained SBP on the day of the
ophthalmic evaluation. All study participants who
agreed to enroll and provide informed consent had
digital stereo images of the macula, optical disc, and
macular OCT scans.
Optical coherence tomography acquisition
A Cirrus HD-OCT instrument (Carl Zeiss Meditec Inc)
was used for this study. Each eye was imaged in a single
session using a volume scan protocol (200 200 mm3)
whose repeatability for drusen quantification has been
well established and described in the previous
publication.13 Each scan covered a retinal area of
6 6 mm2, centered on the fovea, and was obtained after
dilation. The scans were assessed after acquisition and
repeated if necessary to achieve optimal image quality
(signal strength 47).
Quantification of drusen and RA
The raw OCT datasets were exported to a computer for
analysis with an algorithm developed by Zeiss used to
segment the RPE (6.0; Carl Zeiss Meditec Inc), cleared by
the FDA and now commercially available. This
algorithm, which has been recently validated by
comparison with manual segmentation,15,16 uses the RPE
geometry and compares this segmentation map with a
virtual map of the RPE free of deformations (RPE floor)
(Figure 1). Using these two maps, the algorithm creates
an elevation map that permits measurement of drusen
area and volume.13 Elevations of o20 mm are not
included. Areas of atrophy are detected by the algorithm
as contiguous or geographic areas of hyperintensity.
These areas of hyperintensity are evident in partial OCT-
projection maps obtained by summing A-scans from a
choroidal ‘slab’ below the RPE (loss of RPE in lesions
resulted in increased choroidal reflectivity). Eyes with
poor quality scans (signal strength o7) or features of
neovascular AMD, such as subretinal fluid, intraretinal
edema, subretinal tissue, or serous pigment epithelial
detachments, in the OCT B-scans were excluded from
subsequent quantitative lesion analysis. Because an
important component of the planned analyses was to
look for associations between the eyes, if one eye was
ineligible (owing to missing scans, poor quality scans, or
neovascular AMD) both the eyes of that subject were
removed from subsequent analysis.
The Cirrus automated algorithm provided quantitative
measurements of macular drusen area and volume
within a central circle (CC) of 3 mm diameter and a
surrounding perifoveal ring (PR) of 3–5 mm diameter,
both of which were centered on the fovea. The RA
measurements were provided for the entire 6 6 mm2
by the software.
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Statistical methods
The variables considered in this analysis included age
(continuous and separated into four categories: 50–59,
60–69, 70–79, and 480 years of age), gender, past or
present smoking history, years smoked (continuous and
three categories: o5, 6–19, and 420 years), SBP
(continuous and separated into three categories: o120,
120–139, and4140 mm Hg), and the various quantitative
measurements of macular drusen area, drusen volume,
and RA for the right and left eyes. Comparison between
the groups was done by analysis of variance.
Demographic comparisons between males and females
used an independent samples t-test for mean age and
w2-square tests for frequencies by age groups and smoking
status. Because these data included measures for both the
eyes for all subjects, the analyses that tested the
associations with OCT areas and volume used generalized
estimating equations (GEE), which adjusted the
correlation between the eyes. Paired t-tests were used to
compare mean OCT measurements between the right and
left eyes, and Spearman correlations were used to test the
association of continuous age, years smoked (adjusted for
age), and SBP with subject-averaged OCT measures. SAS
V9.2 (SAS Inst., Cary NC, USA) software was used for all
analyses; the accepted level of significance was Po0.05.
Results
A total of 268 subjects were recruited for this study, but
51 subjects were excluded owing to poor quality scans,
missing scans, or features of neovascular AMD on
OCT in at least one eye. Thus, 434 eyes of 217
consecutive subjects were included in this analysis.
The sample included 122 women and 95 men with
a mean age of 73±6.6 years (range 50–89 years). The
majority of the population studied was between 70 and
79 years of age (51.6%). There was no significant
difference in age distribution (P¼ 0.61) between male
and female groups. Twenty-three percent of the
population had a history of smoking, with a much
higher prevalence in the male population (51.6% vs
0.8%, Po0.001). Age distribution and smoking status
are shown in Table 1.
The drusen area and volume measurements were
similar between males and females, but the RA found by
OCT was significantly larger in women (0.63±0.16 vs
0.26±0.08 mm2, P¼ 0.05). For both males and females,
the average drusen area and volume were larger in the
CC than in the PR (Table 2).
One-way analysis of variance determined that the
drusen area, drusen volume, and RA differed among the
various age groups (Po0.001, for all quantitative
measurements). The perifoveal drusen area and volume,
as well as the RA, were larger in older patients. The
drusen area of the CC, in contrast, was relatively similar
in patients of 70 years of age or more, with an area of
0.25±0.06 mm2 for the 70–79-year age group and
0.25±0.07 mm2 for the 480-year age group, and the CC
drusen volume was smaller in the age 480-year age
group (0.009±0.003 mm3) when compared with the
subjects in the 70–79-year age group (0.02±0.008 mm3).
Figure 1 The Cirrus automated algorithm provides quantitative measurements of macular drusen area and volume within a 3 mm
CC and a 3–5 mm surrounding PR. The RA measurements are provided for the entire 6 6 mm2 area. It uses the RPE geometry (black
line) and compares this segmentation map with a virtual map of the RPE free of deformations (pink line). Using these two maps, the
algorithm creates an elevation map that permits measurement of drusen area and volume.
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In the older subjects (the 480-year age group), the
perifoveal drusen area (0.28±0.08 mm2) and volume
(0.01±0.003 mm3) were slightly larger than those of the
CC (0.25±0.07 mm2 and 0.009±0.003 mm3).
PR and CC drusen area and volume and RA
measurements were similar between the nonsmoking
and smoking groups. In the smoking group, however, the
perifoveal drusen area (P¼ 0.05) and volume (P¼ 0.005)
had an increasing correlation with the number of years
smoked (Table 3) when adjusted for age. No significant
difference was noted between the groups with different
smoking duration.
The OCT findings were associated with SBP (Table 3).
Larger drusen area and volume in the PR, as well as RA,
were correlated with increase in SBP. The drusen area in
the CC differed significantly among the SBP groups
(P¼ 0.05). Measurements were 0.07±0.02 mm2 for the
o120 mm Hg group, 0.225±0.07 mm2 for the 120–
139 mm Hg group, and 0.396±0.19 mm2 for the
4140 mm Hg group.
A significant correlation (Po0.001) was found
between the right and left eyes with respect to drusen
area, drusen volume, and RA, as determined by OCT.
CC drusen area and volume showed a stronger
correlation between eyes compared with the PR (for
area r¼ 0.72 vs 0.54 and volume r¼ 0.66 vs 0.58, Po0.001
for all correlations). The correlation coefficient for RA
between eyes was 0.48.
Table 4 demonstrates the relationship between drusen
measurements in the CC and PR, as well as their
relationship with RA in the same eye. The volume
measured appeared to show a similar correlation
compared with area (r¼ 0.75 vs 0.71). The larger RA was
also correlated with larger drusen area in the PR.
Discussion
Segmentation of the retinal layers and measurement of
drusen area, drusen volume, and RA would appear to be
critical for quantitative AMD studies. Automated
algorithms to segment the OCT images accurately and
Table 1 Demographic characteristics of participants
Number (%)
Total Male Female P-valuea
Characteristics 217 95 (43.8) 122 (56.2)
Age, years 0.61T
Mean 73 72.7 73.2
Range 50–89 50–89 51–89
Age group 0.57C
50–59 5 (2.3) 2 (2.1) 3 (2.5)
60–69 58 (26.9) 26 (27.4) 32 (26.5)
70–79 120 (51.6) 49 (51.6) 71 (58.7)
Z80 33 (15.3) 18 (19.0) 15 (12.4)
Unknown 1 1
Smoking status o0.001C
Unknown 9 (4.2) 4 (4.2) 5 (4.1)
Non-smoking 158 (72.8) 42 (44.2) 116 (95.1)
Smoker 50 (23.0) 49 (51.6) 1 (0.8)
Years smoked
Mean 22.1
Range 1–67
r5 12
46–19 13
Z20 22
Unknown 3
a T, independent samples t-test; C, w2 test.
Table 2 Association of age and gender with OCT areas and volumes
Area CC Area PR Volume CC Volume PR RA
Sex, mean±SD
Male (n¼ 95) 0.1695±0.0549 0.1153±0.0372 0.0123±0.0057 0.0051±0.0020 0.2600±0.0878
Female (n¼ 122) 0.2414±0.0629 0.1988±0.0507 0.0165±0.0070 0.0095±0.0032 0.6307±0.1641
P-valuea 0.39 0.18 0.64 0.25 0.05
Age group (years)
50–59 (n¼ 5) 0.0100±0.0089 0.0000±0.0000 0.0002±0.0002 0.0001±0.0001 0.0200±0.0179
60–69 (n¼ 58) 0.1233±0.0507 0.0862±0.0362 0.0077±0.0041 0.0034±0.0016 0.1793±0.0904
70–79 (n¼ 120) 0.2504±0.0698 0.1746±0.0509 0.0202±0.0081 0.0090±0.0034 0.3867±0.1152
Z80 (n¼ 33) 0.2515±0.0783 0.2803±0.0883 0.0094±0.0031 0.0108±0.0036 1.3561±0.4556
P-valuea o0.001 o0.001 o0.001 o0.001 o0.001
Spearman correlation
with continuous age
0.21, P¼ 0.002 0.25, Po0.001 0.25, Po0.001 0.26, Po0.001 0.25, Po0.001
Abbreviations: CC, central circle; PR, perifoveal ring; RA, retinal pigment epithelium atrophy.
a Generalized estimating equations (GEE).
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reproducibly have been described,13–16 and, importantly,
have now become available in commercial devices. In the
present study, we demonstrate that these algorithms may
be used to study and describe drusen and RA burden in
a population-based study of elderly patients.
Our analysis confirms that, in general, larger and more
abundant drusen are found with increasing age, but in
the CC, after the age of 70 years, the drusen volume and
area appear to stabilize and are eventually smaller after
the age of 80 years. Although this correlation between
age and drusen area/volume is statistically significant,
the strength of the association is relatively weak
(r¼ 0.21–0.25), suggesting that many other factors
(eg, genetic and environment) may contribute to the
variability in drusen burden. RA, in contrast, is
progressively larger with advanced age when analyzed
using this segmentation algorithm. Although the RA
algorithm measures the entire 6 6 mm2 and not the CC
alone, one suspects that the increase in the RA in the
central area may account for some of the apparent
decrease in the CC drusen measurements in the
480-year age group. These findings may be consistent
with the regression of soft macular drusen and evolution
of atrophy that has been described in clinical and
hitopathological studies.18 Gass19 first noted that drusen
could fade and disappear, leaving only an irregular
mottling of the RPE. He also observed that most cases of
GA followed the fading of drusen, resulting in
degeneration and atrophy of the RPE and photoreceptors.
Our observations agree with the clinical impression that
GA is rare before the age of 55 years and that it becomes
more common in individuals aged 75 years or older.
Drusen area and volume were similar in males and
females, but interestingly, RA was significantly more
common in women. According to one study, the
diagnosis of late AMD has been reported to be slightly
more frequent in women than in men. In this study
a higher prevalence of neovascular AMD and no
significant difference in GA was observed.20 Other
studies show a similar prevalence of any AMD stage in
males and females.21
Table 3 Association of smoking and SBP with OCT areas and volumes
Area CC Area PR Volume CC Volume PR RA
Smoking status, mean±SD
Nonsmokers (n¼ 158) 0.2117±0.0517 0.1582±0.0397 0.0152±0.0056 0.0075±0.0025 0.5234±0.1301
Smokers (n¼ 50) 0.1950±0.0862 0.1460±0.0614 0.0139±0.0094 0.0069±0.0035 0.3000±0.1372
P-valuea 0.87 0.87 0.91 0.89 0.24
Years smoked
r5 (n¼ 12) 0.0667±0.0596 0.0042±0.0040 0.0041±0.0038 0.0000±0.0000 0.0125±0.0120
6–19 (n¼ 13) 0.4269±0.3052 0.1885±0.1488 0.0403±0.0347 0.0123±0.0110 0.1077±0.0995
Z20 (n¼ 22) 0.1545±0.0515 0.2159±0.1041 0.0055±0.0019 0.0083±0.0042 0.4705±0.2699
P-valuea 0.32 0.06 0.59 0.08 0.15
SBP, mmHg
o120 (n¼ 68) 0.0772±0.0258 0.0985±0.0396 0.0029±0.0010 0.0040±0.0017 0.3059±0.1389
120–139 (n¼ 66) 0.2250±0.0738 0.1568±0.0626 0.0136±0.0063 0.0082±0.0047 0.3614±0.1569
Z140 (n¼ 31) 0.3968±0.1913 0.2839±0.1195 0.0370±0.0244 0.0128±0.0067 0.9565±0.3784
P-valuea 0.05 0.29 0.09 0.34 0.27
Spearman correlation with
continuous years smoked, adjusted for age
0.23, P¼ 0.12 0.29, P¼ 0.05 0.20, P¼ 0.17 0.40, P¼ 0.005 0.24, P¼ 0.10
Spearman correlation with continuous SBP 0.06, P¼ 0.42 0.18, P¼ 0.01 0.08, P¼ 0.26 0.18, P¼ 0.02 0.15, P¼ 0.05
Abbreviations: CC, central circle; OCT, optical coherence tomography; PR, perifoveal ring; RA, retinal pigment epithelium atrophy; SBP, systolic blood
pressure.
aGeneralized estimating equations (GEE).
Table 4 Correlations between RPE atrophy area and drusen
area and volume in the CC and PR
Variable 1 Variable 2 Spearman correlation
coefficient
P-value
Area CC Area PR 0.71 o0.001
Volume CC Volume PR 0.75 o0.001
Area CC RA 0.48 o0.001
Area PR RA 0.67 o0.001
Volume CC RA 0.52 o0.001
Volume PR RA 0.63 o0.001
Abbreviations: CC, central area; PR, perifoveal ring; RA, retinal pigment
epithelium atrophy.
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Cigarette smoking has been found to be related to late
age-related maculopathy in some,22–25 but not all,26–29
epidemiologic studies. A smoking history was neither
associated with larger drusen area and volume, nor with
RA in our population. In part, the small number of cases,
particularly of women smokers, may explain this. We did
not make any distinction between current past smoking
history, and possibly some of our subjects were former
smokers. It has been reported that, although previous
smoking history also increases the progression of AMD,
current smoking is more likely to increase the incidence
of AMD lesions.29 McCarty et al30 argued that the total
duration of smoking history was the most significant
factor for development of AMD rather than pack years,
current, or former smoking status. In other studies,31 the
pack years of cigarette smoking has proven to be a better
correlate than the number of years of smoking, and it was
the most significant risk factor for AMD. A dose–
response effect has been demonstrated: the risk of
developing AMD increases as the intensity of smoking
increases.32 In our Amish population, an increased
duration of smoking did appear to be associated with a
larger drusen area and volume in the PR.
In the present study, an increase in SBP was directly
correlated with larger drusen area and volume in the
perifoveal zone and with larger RA. The relationship
between blood pressure and AMD has proven to be
inconsistent in epidemiologic population-based studies,
with some studies suggesting an increased risk of
developing AMD with increased pulse pressure.21 In the
Beaver Dam study, SBP, hypertension, and pulse pressure
were significantly associated with RPE depigmentation,
progression of AMD, and incidence of neovascular AMD,
but not GA.33 The mechanism by which hypertension can
increase the risk of AMD is not immediately apparent.
However, age-related degenerative changes in collagen and
elastin are known to produce a decrease in the distensibility
of blood vessels.34 This in turn results in higher SBP and
lower diastolic blood pressure and widening of the pulse
pressure. Klein et al33 postulated that a wide pulse pressure
may be a marker of similar degenerative changes also
occurring in the Bruch membrane of these individuals’
eyes, thus increasing the risk of development and
progression of AMD. Although we found a significant
correlation, our conclusions are limited as the blood
pressure reading was acquired just once and may not
reflect a chronic systemic hypertension diagnosis.
The right and left eyes of subjects demonstrate a high
correlation in drusen and RA measurements using the
automated OCT algorithms. This finding is in agreement
with a previous analysis that demonstrated good to
excellent symmetry for all ophthalmoscopic and
fluorescein angiographic characteristics of drusen in
the central and peripheral areas of the posterior pole
between both the eyes of subjects with AMD.35
Sunness et al36 described a high correlation in the size
and progression of GA between both eyes. Studies
suggest that 48–65% of prevalent GA cases show bilateral
involvement.37 Thus, our automated OCT observations of
RA are consistent with previous observations of bilateral
incidence38 and with ophthalmoscopic assessment of
AMD symmetry.19,39
Despite these apparent observations and associations,
our study is not without limitations. First, although this
was a population study, we only studied individuals
aged 50 years or older. Thus, information about OCT-
quantified drusen burden in younger individuals is
unknown. Our study does demonstrate that OCT-based
assessment can be applied to population analyses.
Furthermore, our OCT data may be correlated with
future genetic information that may be forthcoming
from this population. Second, our analysis only used the
automated quantitative data provided by the
instrument. We did not perform additional qualitative
analysis of drusen morphology or other OCT features of
AMD, such as the presence of intraretinal
hyperreflective foci (known to correlate with areas of
RPE migration), nor did we correct subtle segmentation
errors. On the other hand, by using commercial
algorithms that had been FDA-cleared and previously
validated for reliability and accuracy, the data
considered in our analysis can easily be compared with
the data obtained in future studies in other and larger
populations. Third, the commercial drusen
segmentation algorithm only includes RPE elevations
that exceed a threshold of 20 mm. Although very shallow
drusen are likely to be ignored by this analysis, they
would probably only contribute a small amount to the
total area or volume in eyes with significant numbers of
larger drusen even if they were to be included. Fourth,
color fundus photographs were not classified or
compared with the drusen and RA segmented by the
software. Color fundus photographs offer potentially
complementary information to SD-OCT and both may
have an important role in assessing drusen and GA in
patients with non-exudative AMD.11 While this would
have been an interesting analysis, this has been
evaluated in other studies.40 Finally, the commercial RA
segmentation algorithm was designed to include all
contiguous areas that demonstrated significant
transmission of light into the choroid with associated
increased choroidal reflectivity. Although these
measurements have been shown to compare favorably
with fundus autofluorescence-based measures of RA,41
areas of severe depigmentation of the RPE without
actual loss of the RPE may produce a similar
appearance on OCT and thus may be inadvertently
included in the OCT-derived RA measurements.
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Polarization-sensitive SD-OCT combines the advantage
of SD-OCT imaging with a selective identification of the
polarization state of backscattered light. Because the
melanosomes of the RPE change the polarization state in
a random manner,
PS-OCT is capable of precisely depicting its exact
location and configuration. This selectivity can be used
for a reliable automated segmentation of alterations at
the retina–RPE boundary.42 Further studies are needed
to evaluate the differences between the two methods.
Despite these limitations, the OCT-derived automated
analyses in the Amish population suggest that
increasing age appears to be an important risk factor for
increased OCT drusen area and volume in the CC and
PR although this increase in drusen area in the CC does
not continue after the age of 70 years. Drusen and RA
measurements are highly correlated and similar
between the eyes of the same individual. The number of
continuous years smoked and SBP are also associated
with an increased area and volume of perifoveal drusen.
Female gender, age, and SBP are all associated with RA
to a greater extent. These findings may be useful as a
starting point in guiding future, larger, population-
based studies on the prevalence of features of non-
neovascular AMD, and in better phenotyping and
characterization of populations for genetic association
studies.
Summary
What was known before
K Color fundus photography was the only imaging
modality used to evaluate the severity and progression of
AMD in major epidemiologic eye disease studies.
K This imaging technique has limitations with regard to the
measurement of RPE atrophy and to the precise
quantification of drusen boundaries.
K OCT provides the opportunity to assess the effect of
drusen and RA on the geometry of the RPE in vivo.
What this study adds
K Automated OCT-based assessment of lesions associated
with non-neovascular AMD can be applied to population
analyses and may allow for more complete and
quantitative assessment of patients for longitudinal
assessments.
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